vs
McEwen Inc.（MUX）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
McEwen Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.8倍（$64.6M vs $35.5M），McEwen Inc.净利率更高（59.0% vs -304.2%，领先363.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 92.8%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 25.2%）
McEwen Inc（股票代码MUX）是一家自然资源企业，主要从事金、银、铜矿产的勘探、开发与生产业务，运营项目分布于南北美洲，秉持可持续负责任的采矿准则，产品面向全球大宗商品市场供应。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
MUX vs RXRX — 直观对比
营收规模更大
MUX
是对方的1.8倍
$35.5M
营收增速更快
RXRX
高出589.0%
92.8%
净利率更高
MUX
高出363.2%
-304.2%
两年增速更快
RXRX
近两年复合增速
25.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $64.6M | $35.5M |
| 净利润 | $38.1M | $-108.1M |
| 毛利率 | 26.9% | 59.8% |
| 营业利润率 | 34.2% | -304.8% |
| 净利率 | 59.0% | -304.2% |
| 营收同比 | 92.8% | 681.7% |
| 净利润同比 | 563.1% | 39.6% |
| 每股收益（稀释后） | $0.66 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MUXRXRX
| Q4 25 | $64.6M | $35.5M | ||
| Q3 25 | $50.5M | $5.2M | ||
| Q2 25 | $46.7M | $19.2M | ||
| Q1 25 | $35.7M | $14.7M | ||
| Q4 24 | $33.5M | $4.5M | ||
| Q3 24 | $52.3M | $26.1M | ||
| Q2 24 | $47.5M | $14.4M | ||
| Q1 24 | $41.2M | $13.8M |
净利润MUXRXRX
| Q4 25 | $38.1M | $-108.1M | ||
| Q3 25 | $-462.0K | $-162.3M | ||
| Q2 25 | $3.0M | $-171.9M | ||
| Q1 25 | $-6.3M | $-202.5M | ||
| Q4 24 | $-8.2M | $-178.9M | ||
| Q3 24 | $-2.1M | $-95.8M | ||
| Q2 24 | $-13.0M | $-97.5M | ||
| Q1 24 | $-20.4M | $-91.4M |
毛利率MUXRXRX
| Q4 25 | 26.9% | 59.8% | ||
| Q3 25 | 15.5% | -183.8% | ||
| Q2 25 | 26.3% | -4.9% | ||
| Q1 25 | 28.2% | -48.0% | ||
| Q4 24 | 1.1% | -181.4% | ||
| Q3 24 | 26.4% | 53.7% | ||
| Q2 24 | 22.7% | 36.2% | ||
| Q1 24 | 14.6% | 19.1% |
营业利润率MUXRXRX
| Q4 25 | 34.2% | -304.8% | ||
| Q3 25 | -16.7% | -3327.6% | ||
| Q2 25 | -7.2% | -916.8% | ||
| Q1 25 | -21.4% | -1297.9% | ||
| Q4 24 | -43.4% | -4042.4% | ||
| Q3 24 | -0.2% | -377.1% | ||
| Q2 24 | -29.4% | -697.4% | ||
| Q1 24 | -53.3% | -698.4% |
净利率MUXRXRX
| Q4 25 | 59.0% | -304.2% | ||
| Q3 25 | -0.9% | -3135.3% | ||
| Q2 25 | 6.5% | -894.2% | ||
| Q1 25 | -17.6% | -1373.3% | ||
| Q4 24 | -24.6% | -3935.5% | ||
| Q3 24 | -4.0% | -367.5% | ||
| Q2 24 | -27.4% | -676.6% | ||
| Q1 24 | -49.4% | -662.4% |
每股收益（稀释后）MUXRXRX
| Q4 25 | $0.66 | $-0.17 | ||
| Q3 25 | $-0.01 | $-0.36 | ||
| Q2 25 | $0.06 | $-0.41 | ||
| Q1 25 | $-0.12 | $-0.50 | ||
| Q4 24 | $-0.15 | $-0.56 | ||
| Q3 24 | $-0.04 | $-0.34 | ||
| Q2 24 | $-0.26 | $-0.40 | ||
| Q1 24 | $-0.41 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.1M | $743.3M |
| 总债务越低越好 | $126.2M | $9.6M |
| 股东权益账面价值 | $546.2M | $1.1B |
| 总资产 | $820.2M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.23× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资MUXRXRX
| Q4 25 | $72.1M | $743.3M | ||
| Q3 25 | $75.4M | $659.8M | ||
| Q2 25 | $69.5M | $525.1M | ||
| Q1 25 | $79.3M | $500.5M | ||
| Q4 24 | $15.3M | $594.4M | ||
| Q3 24 | $30.2M | $427.6M | ||
| Q2 24 | $42.6M | $474.3M | ||
| Q1 24 | $22.0M | $296.3M |
总债务MUXRXRX
| Q4 25 | $126.2M | $9.6M | ||
| Q3 25 | $126.0M | $11.9M | ||
| Q2 25 | $125.8M | $14.2M | ||
| Q1 25 | $125.5M | $16.4M | ||
| Q4 24 | $40.0M | $19.0M | ||
| Q3 24 | $31.0M | $20.5M | ||
| Q2 24 | $34.0M | $22.9M | ||
| Q1 24 | $37.0M | — |
股东权益MUXRXRX
| Q4 25 | $546.2M | $1.1B | ||
| Q3 25 | $488.6M | $1.0B | ||
| Q2 25 | $484.5M | $919.1M | ||
| Q1 25 | $479.8M | $933.9M | ||
| Q4 24 | $495.0M | $1.0B | ||
| Q3 24 | $502.1M | $524.6M | ||
| Q2 24 | $485.2M | $584.4M | ||
| Q1 24 | $482.5M | $401.2M |
总资产MUXRXRX
| Q4 25 | $820.2M | $1.5B | ||
| Q3 25 | $747.6M | $1.4B | ||
| Q2 25 | $735.6M | $1.3B | ||
| Q1 25 | $730.6M | $1.3B | ||
| Q4 24 | $664.6M | $1.4B | ||
| Q3 24 | $667.8M | $726.5M | ||
| Q2 24 | $645.1M | $775.9M | ||
| Q1 24 | $638.7M | $557.8M |
负债/权益比MUXRXRX
| Q4 25 | 0.23× | 0.01× | ||
| Q3 25 | 0.26× | 0.01× | ||
| Q2 25 | 0.26× | 0.02× | ||
| Q1 25 | 0.26× | 0.02× | ||
| Q4 24 | 0.08× | 0.02× | ||
| Q3 24 | 0.06× | 0.04× | ||
| Q2 24 | 0.07× | 0.04× | ||
| Q1 24 | 0.08× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | 0.08× | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流MUXRXRX
| Q4 25 | $3.1M | $-46.1M | ||
| Q3 25 | $5.2M | $-117.4M | ||
| Q2 25 | $478.0K | $-76.4M | ||
| Q1 25 | $-1.9M | $-132.0M | ||
| Q4 24 | $-1.2M | $-115.4M | ||
| Q3 24 | $23.2M | $-59.2M | ||
| Q2 24 | $3.6M | $-82.2M | ||
| Q1 24 | $3.9M | $-102.3M |
自由现金流MUXRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率MUXRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度MUXRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率MUXRXRX
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.16× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
